BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 11069318)

  • 1. Endoscopic injection of botulinum toxin in patients with recurrent acute pancreatitis due to pancreatic sphincter of Oddi dysfunction.
    Wehrmann T; Schmitt TH; Arndt A; Lembcke B; Caspary WF; Seifert H
    Aliment Pharmacol Ther; 2000 Nov; 14(11):1469-77. PubMed ID: 11069318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endoscopic injection of botulinum toxin for biliary sphincter of Oddi dysfunction.
    Wehrmann T; Seifert H; Seipp M; Lembcke B; Caspary WF
    Endoscopy; 1998 Oct; 30(8):702-7. PubMed ID: 9865560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin injection after biliary sphincterotomy.
    Gorelick A; Barnett J; Chey W; Anderson M; Elta G
    Endoscopy; 2004 Feb; 36(2):170-3. PubMed ID: 14765315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum toxin may predict the outcome of endoscopic sphincterotomy in episodic functional post-cholecystectomy biliary pain.
    Murray W; Kong S
    Scand J Gastroenterol; 2010 May; 45(5):623-7. PubMed ID: 20156033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Sphincter of Oddi disfunction in "idiopathic" recurrent pancreatitis].
    Wehrmann T; Zipf A; Caspary WF; Jung M
    Dtsch Med Wochenschr; 1996 Jun; 121(24):781-7. PubMed ID: 8654212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum toxin injection as a diagnostic tool for verification of sphincter of Oddi dysfunction causing recurrent pancreatitis.
    Muehldorfer SM; Hahn EG; Ell C
    Endoscopy; 1997 Feb; 29(2):120-4. PubMed ID: 9101150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcome of endoscopic dual pancreatobiliary sphincterotomy in patients with manometry-documented sphincter of Oddi dysfunction and normal pancreatogram.
    Park SH; Watkins JL; Fogel EL; Sherman S; Lazzell L; Bucksot L; Lehman GA
    Gastrointest Endosc; 2003 Apr; 57(4):483-91. PubMed ID: 12665757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrasphincteric injection of botulinum toxin for suspected sphincter of Oddi dysfunction.
    Pasricha PJ; Miskovsky EP; Kalloo AN
    Gut; 1994 Sep; 35(9):1319-21. PubMed ID: 7959245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and predictors of post-ERCP pancreatitis in patients with suspected sphincter of Oddi dysfunction undergoing biliary or dual sphincterotomy: results from the EPISOD prospective multicenter randomized sham-controlled study.
    Yaghoobi M; Pauls Q; Durkalski V; Romagnuolo J; Fogel EL; Tarnasky PR; Aliperti G; Freeman ML; Kozarek RA; Jamidar PA; Wilcox CM; Elta GH; Hawes RH; Wood-Williams A; Cotton PB
    Endoscopy; 2015 Oct; 47(10):884-90. PubMed ID: 26165739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ERCP, biliary crystal analysis, and sphincter of Oddi manometry in idiopathic recurrent pancreatitis.
    Kaw M; Brodmerkel GJ
    Gastrointest Endosc; 2002 Feb; 55(2):157-62. PubMed ID: 11818915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnostic and therapeutic possibilities in suspected Oddi's sphincter dysfunction].
    Wehrmann T; Lembcke B; Jung M
    Z Gastroenterol; 1994 Dec; 32(12):694-701. PubMed ID: 7871862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sphincter of Oddi (pancreatic) hypertension and recurrent pancreatitis.
    Devereaux BM; Sherman S; Lehman GA
    Curr Gastroenterol Rep; 2002 Apr; 4(2):153-9. PubMed ID: 11900681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of intrasphincteric botulinum toxin injection in the management of functional biliary pain: a systematic review and meta-analysis.
    Menon S; Kurien R; Mathew R
    Eur J Gastroenterol Hepatol; 2020 Aug; 32(8):984-989. PubMed ID: 32453006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sphincter of Oddi dysfunction: pancreaticobiliary sphincterotomy with pancreatic stent placement has a lower rate of pancreatitis than biliary sphincterotomy alone.
    Fogel EL; Eversman D; Jamidar P; Sherman S; Lehman GA
    Endoscopy; 2002 Apr; 34(4):280-5. PubMed ID: 11932782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic stenting prevents pancreatitis after biliary sphincterotomy in patients with sphincter of Oddi dysfunction.
    Tarnasky PR; Palesch YY; Cunningham JT; Mauldin PD; Cotton PB; Hawes RH
    Gastroenterology; 1998 Dec; 115(6):1518-24. PubMed ID: 9834280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sphincter of Oddi dysfunction in children with recurrent pancreatitis and anomalous pancreaticobiliary union: an etiologic concept.
    Guelrud M; Morera C; Rodriguez M; Jaen D; Pierre R
    Gastrointest Endosc; 1999 Aug; 50(2):194-9. PubMed ID: 10425412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypertensive pancreatic sphincter.
    Lehman GA; Sherman S
    Can J Gastroenterol; 1998; 12(5):333-7. PubMed ID: 9773212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin-induced relaxation of the sphincter of Oddi may select patients with acalculous biliary pain who will benefit from cholecystectomy.
    Murray WR
    Surg Endosc; 2011 Mar; 25(3):813-6. PubMed ID: 20665051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endoscopic bile duct stent placement as a predictor of outcome following endoscopic sphincterotomy in patients with suspected sphincter of Oddi dysfunction.
    Rolny P
    Eur J Gastroenterol Hepatol; 1997 May; 9(5):467-71. PubMed ID: 9187879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do patients with sphincter of Oddi dysfunction benefit from endoscopic sphincterotomy? A 5-year prospective trial.
    Wehrmann T; Wiemer K; Lembcke B; Caspary WF; Jung M
    Eur J Gastroenterol Hepatol; 1996 Mar; 8(3):251-6. PubMed ID: 8724026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.